Triple therapy with mycophenolate mofetil versus azathioprine

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1144-1146

  Muniz M L ^a   Amenabar, J ^a   Gomez Ullate P ^a   Urbizu, J ^a   Lampreabe, I ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3;

ADJUVANT THERAPY; ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; GRAFT SURVIVAL; HEPATITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; MORTALITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AZATHIOPRINE; CAUSE OF DEATH; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISONE; SURVIVAL ANALYSIS;

EID: 0344699468     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01939-3     Document Type: Conference Paper

References (6)

1. Deierhoi M.H., Sollinger H.W., Diethelm A.G., et al. Transplant Proc. 25:1993;693.
2. Transplantation. 61:1996;1029.
3. Transplantation. 61:1996;1029.
4. Lancet. 345:1995;1321.
5. Lipsky J. Lancet. 348:1996;1357.
6. Halloran P., Mathew T., Tomlanovich S., et al. Transplantation. 63:1997;39.